健康的生活方式改變讓你發現一個全新的自我

Isotonix®基本營養組合包

4.9
(85 評論)
產品代號(sku) HK6496

HK$644.00 HKD

HK$12.88 HKD 現金回贈

此產品符合免運費或優惠運費資格。 了解更多資訊

益處

益處
• 促進強效的抗氧化保護
• 支援心血管健康
• 補充日常飲食不足
• 支援免疫系統
• 支持骨骼健康
• 支援牙齒與牙齦健康
• 支援能量和產生能量

產品分類


不含麩質 - 本產品不含可檢測出之麩質*


不含可檢測出之基改成份(GMO) - 本產品不含可檢測出之基因改造生物成份


素食品 - 本產品為素食產品


等滲壓營養補充沖飲 - 易於飲用的營養補充品 / 健康食品，透過等滲壓狀態達致更佳的營養吸收


品質標準 - 良好生產規範(GMP)運作與標準化成份


已檢測：重金屬丶微生物污染物丶過敏原丶效力丶純度及特性

*美國食品藥品監督管理局（FDA）將含有少於20PPM麩質的製成產品列為不含麩質

詳細資料

結合四種最受歡迎及必需的營養補充品包裝，方便攜帶！
• Isotonix OPC-3®沖飲
現今市場上最強效的抗氧化營養補充品！
• Isotonix®綜合維他命沖飲
獲得全方位營養！
• Isotonix®全效維他命B沖飲
全面補充維他命B
• Isotonix®鈣高效吸收沖飲
維持骨骼強壯、牙齒與牙齦健康不可或缺的營養素

沒甚麼比每日照顧好自己的健康更重要。Isotonix基本營養組合包提供身體所需的維他命、礦物質及營養。Isotonix基本營養組合包包含Isotonix OPC-3沖飲、Isotonix綜合維他命沖飲、Isotonix全效維他命B沖飲及Isotonix鈣高效吸收沖飲。方便的獨立包裝，支援你長久的健康及最佳營養。此外，相對於獨立購買這四種單瓶裝的產品，Isotonix基本營養組合包讓你節省更多！維持整體健康的首選 ─ Isotonix OPC-3沖飲，提供許多對整體健康好處的強效抗氧化物。Isotonix OPC-3沖飲有助關節靈活、心血管健康和循環，對抗體內的自由基，讓身體發揮最佳功能。Isotonix綜合維他命沖飲包含每日必需的維他命及礦物質以補足你膳食中的營養。在現今繁忙的生活節奏下，確保身體吸收了足夠的養分至關重要。Isotonix®綜合維他命沖飲能補足飲食不均的問題，並協助維持正常的新陳代謝。每包組合包含有Isotonix全效維他命B沖飲，結合了必需的維他命B群、鎂和鉀，提供足夠全日所需的能量。兩者發揮協同運作，促進體內眾多的健康好處和生物過程。此產品提供維他命B-12、B2（核黃素）、B6、葉酸、維他命B3（菸酸）、B5、B1和生物素。支援正常紅血球細胞形成、能量水平及心血管健康。缺乏維他命B會導致疲勞與精神不振，因此維他命B補充品在提神與減壓方面是很好的選擇。最後Isotonix鈣高效吸收沖飲提供強效鈣質及附加營養素，以維持你的骨骼強健。身體很難從片劑形式的鈣片吸收鈣質，我們獨特的Isotonix等壓吸收傳輸系統能將Isotonix鈣高效吸收沖飲中的維他命D及其他對身體有好處的維他命與礦物質更容易傳遞至體內，讓身體快速吸收與運用。
詳細資料

成份

葡萄籽萃取物
葡萄籽萃取物一般提取自紅葡萄（而非白葡萄）的籽，含有大量稱為原花色素(OPC)的複合物，以及具抗氧化功效的多酚類。葡萄籽富含具強效抗氧化功效的多酚類複合物。

紅酒萃取物
紅酒萃取物是強效抗氧化物，存在於葡萄的藤、根、籽及莖中，葡萄皮中的含量最高。紅酒萃取物的抗氧化特質能鞏固微血管、動脈和靜脈，有助維持健康的血液循環和提升整體心血管健康。

90年代末，科學家注意到法國人的一個現象。某些省份的人進食較高脂肪的食物並同時飲用紅酒，而從古至今這些人患有心臟問題的比率非常低。科學家得出結論：紅酒所具有的保護特性多年來幫助法國人維持心臟健康。後續的科學研究更進一步證實，紅酒中所含的OPCs對維護心臟和血管的健康大為有益。

松樹皮萃取物（碧容健®，Pycnogenol®）
碧容健® （Pycnogenol®）是由海岸松樹皮萃取的天然植物萃取物，這種海岸松樹只生長在法國西南部沿岸的加斯科尼地區。這片不受污染的天然樹林就是碧容健®的唯一來源。碧容健®是天然產品巿場上，最受廣泛研究的成分之一。發表的研究報告顯示，碧容健®對身體健康有許多好處。松樹皮萃取物結合全天然原花青素、生物類黃酮及有機酸。

此萃取物擁有三項基本特質：抗氧化、選擇性結合膠原蛋白及彈力蛋白，以及協助內皮細胞製造一氧化氮，一氧化氮能促進血管的正常舒張。
碧容健®作為最強效、天然的自由基對抗物，能去除所有具侵略性的自由基，使自由基不能藉著氧化壓力損害人體。碧容健®的強超抗氧化能力有助支援健康的血小板活動，緩解輕度經痛與腹痛，維持關節靈活，促進心血管健康，並支援健康膚色。

歐洲藍莓萃取物
來自一種普遍歐洲常見的矮灌木，取其葉子與像莓子的果實，這種矮灌木是藍莓的非常近似。成熟的歐洲藍莓萃取物含有稱為花青素的類黃酮色素，是強效的抗氧化物。科學研究證明，歐洲藍莓有助支援健康的視力及靜脈血液循環，歐洲藍莓萃取物能鞏固微血管、動脈和靜脈，有助維持健康的血液循環。

柑橘類萃取物（生物類黃酮）
生物類黃酮是存在於部份植物的抗氧化物，也是吸收紫外線輻射的光線過濾器，保護容易受損的DNA鏈以及其他重要的大分子。現已發現生物類黃酮能改善心血管健康，具有抗炎作用，同時鞏固微血管、動脈和靜脈，繼而維持良好的血液循環。

維他命A（β-胡蘿蔔素／維他命A前導物）維他命A為脂溶性維他命。維他命的來源包括動物內臟（如肝臟和腎臟）、蛋黃、牛油、紅蘿蔔汁、南瓜、番薯、菠菜、桃、強化奶製品和鱈魚肝油。維他命A屬於視黃醇、視黃醛和β-胡蘿蔔素等複合物家族。β-胡蘿蔔素亦是維他命A原，當身體有額外需求時，便會轉化成維他命A。維他命A提供全身組織的正常發育及修護。維他命A能促進良好的夜視能力，支援正常的骨骼成長，協助抗氧化防禦，並支援健康的免疫系統。

維他命C（抗壞血酸） 
維他命C存在於椒類（甜椒、青椒、紅椒、紅辣椒及青辣椒）、柑橘類水果、結球甘藍、椰菜花、椰菜、羽衣甘藍、芥蘭、芥菜、西蘭花、菠菜、番石榴、奇異果、黑加侖及士多啤梨等。堅果類及穀類亦含有微量的維他命C，維他命C的活性很容易因烹煮而受損。
維他命C支援健康的免疫系統，促進心血管健康，並且提供抗氧化功能。人體無法自行製造及儲存維他命C。因此，維他命C必須透過飲食和營養補充品而取得。

硫胺素（維他命B1）
硫胺素對碳水化合物的正常代謝，和維持健全的神經系統扮演重要的角色。健康的神經系統需要硫胺素，協助製造神經傳導物質乙醯膽鹼和γ-胺基丁酸（GABA）。

泛酸（維他命B5）
泛酸(B5) 是幫助膽鹼轉化為乙酰膽鹼的轉換器。乙酰膽鹼有助維持正常的大腦神經傳導活動。

菸鹼酸(維他命B3)
維他命B3是水溶性的維他命，對健康、生長和生殖的許多層面來說都是必需的。它是維他命B群之一。菸鹼酸幫助維持正常的消化系統，以及皮膚和神經的運作。同時也有助轉化食物為能量。菸鹼酸（一般又稱為維他命B3）多存在於奶類製品、家禽、魚類、瘦肉、堅果、蛋、豆類、營養強化麵包以及早餐穀類中。

維他命B12（氰鈷胺）
維他命B12天然存在於在肉類、肝臟、牛肉、豬肉、蛋類、全脂牛奶、乳酪、全麥麵包和魚類中。維他命B12主要只能從動物製品中獲得，另外有少量來自發酵豆類製品，例如味噌、豆豉及花生。素食者必須使用維他命B12補充品以維持最佳的健康狀態。維他命B12在攝取後儲存於肝臟和其他組織內，以供日後使用。合成的維他命B12，又稱氰鈷胺，是無法由植物或動物本身萃取，對於維護細胞正常功能有著舉足輕重的影響力。這些組織會率先顯示出維他命B12不足的跡象。維他命B12本身負責維持最佳能量水平，因為它在克氏循環(Krebs energy cycle)中扮演關鍵角色。維他命B12同時也是一種重要的抗衰老元素，並有助集中注意力。

葉酸
葉酸主要存在於蔬果中。深綠色蔬菜、橙、橙汁、豆類、豌豆和啤酒酵母是提供葉酸的最佳來源。葉酸在提升B12補充品效用方面擔當關鍵的角色。這兩種維他命B協力合作，維護正常的紅血球細胞。葉酸有助氨基酸及蛋白質的正常使用，並促進製造脫氧核糖核酸DNA與核糖核酸RNA物質的合成，是身體所有功能必需的。科學研究發現當維他命B12與葉酸一起運作時，能支援正常的半胱胺酸水平。這有助支持健康的心血管與神經系統。

核黃素-5-磷酸鹽 （維他命B2）
維他命B2存在於肝臟、奶類製品、深綠色蔬菜和某些種類的海鮮。維他命B2是一種輔酵素，和其他的維他命B產生協同作用。維他命B2促進血液和神經系統的健康，以及正常人體生長。它可支援皮膚、指甲和頭髮的健康生長。維他命B2在食物轉換為能量的過程中扮演關鍵的角色，是電子傳送鏈的一部分，能給予細胞能量。維他命B2用作於激活維他命B6和葉酸同時，有助分解脂肪。維他命B2為水溶性，除非攝取量非常不足，否則無法儲存於人體內，因此必須每日補充。在某些情況下，維他命B2可作為抗氧化物。核糖黄素輔酶有助轉化維他命B6及葉酸的活性，同時幫助色胺酸轉化為菸鹼酸。

鹽酸吡哆辛（維他命B6）
維他命B6的主要來源是家禽、魚類、全穀類和香蕉。維他命B6是一種輔酵素，參與蛋白質和胺基酸的代謝轉化，並且幫助維持體液平衡，維他命B6有助維護健康的紅血球和白血球細胞。維他命B6參與血紅蛋白的合成。它參與腦和周圍神經細胞中神經遞質的合成，它被推薦作為一種營養素來增強心理功能，特別是情緒，並支援正常的神經傳導。維他命B6與葉酸一起食用時，已被證明有幫助維持同型半胱氨酸的正常血漿水平，從而促進心血管的健康。

維他命D3 (膽鈣化醇) 
大多數人主要從太陽光中獲取維他命D。維他命D的飲食來源包括添加維他命D的牛奶（每杯含100 IU國際單位）、鱈魚肝油及富含脂肪的魚類，例如三文魚。蛋黃和肝臟含有少量的維他命D。維他命D能幫助吸收鈣質和磷，並協助製造幾種有助於鈣質吸收和儲存的蛋白質。維他命D與鈣兩者共同促進骨骼強壯。它能協助將骨細胞中的鈣質，運送至細胞外液和腎臟，促進腎小管順利吸收磷和鈣。維他命D有助腸道壁表面細胞正常吸收從飲食中攝取的鈣和磷。它促進組織健康生長及修護，並且維護皮膚的整體健康。

維他命E（d-α-生育醇琥珀酸酯）
維他命E重要的飲食來源包括蔬菜油、人造牛油、果仁、種籽、牛油果和小麥胚芽。紅花油富含大量的維他命E (¼杯中就約有⅔的每日建議攝取量)，而粟栗米油和大豆油中僅含有微量。維他命 E 和生育醇 (tocopherols) 與三烯生育醇 (tocotrienols) 同屬相關的複合物家族 維他命 E有天然或合成形式。絕大多數時，天然形式和合成形式都是一樣，但天然形式的維他命E較能在體內吸收及留存。天然形式的α生育醇又被稱為d-α生育醇 （天然形式存在於Isotonix綜合維他命沖飲中）。合成形式dl-最常見於膳食補充品。在執行體重管理的人通常會注重飲食中脂肪的攝取量，他們由於減少攝取脂肪含量較高的食物，因此有可能也減少維他命E的攝取。
維他命E主要的功能在於它可促進免疫功能的抗氧化活動。維他命E亦能支援正常的癒合，並且促進心血管健康。維他命E是體內最有效的脂溶性抗氧化物之一。維他命E更能保護細胞膜免受自由基的傷害。

鈣（乳酸，磷酸鹽）
鈣質存在於牛奶、芝士、乳酪、墨西哥玉米餅、大白菜、羽衣甘藍和西蘭花中。鈣質是重要的礦物質，具有多項生物功能。鈣質主要以氫氧基磷灰石的形式，Ca10 (PO4)6 (OH)2，存在於骨骼之中。氫氧基磷灰石大約佔骨骼重量40%。骨骼是主要需要補充鈣質的人體結構，而且骨骼也是鈣質的儲藏室。鈣質是構建骨骼與牙齒的，同時促進正常的肌肉收縮、神經傳導及心血管健康，有助製造能量和維持健康的免疫系統。

要維持骨質密度及健康的牙齒與骨骼，每天必須補充足夠的鈣質。鈣質顯示能紓緩婦女的更年期症狀。若沒有每日攝取足夠的鈣質，身體會從骨骼中吸取鈣質，進而造成骨質流失和骨質疏鬆。骨質疏鬆是和年紀相關的骨質流失現象，可能導致危險的髖關節、肋骨、骨盆、以及其它衰老部位的骨頭斷裂。除骨質疏鬆外，高齡也會導致因為脊椎小部位的斷裂，慢慢累積而成的彎腰駝背。

鉻 (肌醇) 
鉻天然存在於某些穀類、肉類、家禽類、啤酒酵母、西蘭花、西梅、菇類、魚類及啤酒。鉻已被證明有助於減少體內脂肪，控制飢餓感並抑制食慾。許多體重管理行業的人認為鉻是控制體重的重要礦物質。鉻也可能幫助身體結實和增加肌肉。

銅(葡萄糖酸鈣)
 銅的最佳飲食來源是內臟、海鮮、堅果、種籽、小麥麩皮穀類、全麥製品、以及可可類產品。銅或具抗氧化功效，同時在鐵的代謝過程中扮演酵素成分的角色。銅是一種是很重要的微量礦物質。銅對於正常嬰兒發展、鐵質輸送、骨骼強度、心肌收縮、大腦發育及免疫功能，都是必須的。

碘(碘化鉀) 
碘存在於大部分的海鮮及加碘食鹽。它有助於調節和維持正常的新陳代謝運作。

鎂（碳酸鹽）
富含鎂的食物包括未經打磨的穀物、果仁和綠色蔬菜。綠色葉菜類是鎂的豐富來源，因為其中含有葉綠素。肉類、澱粉類和牛奶中的鎂含量較少。精製加工食物一般鎂含量都相當低。鎂是協助骨骼礦物化的元素之一，是成人代謝鉀和鈣所不可或缺的成分。有助維持體內鉀、磷及鈣的含量於正常水平。對鈣的調動也十分重要，將鈣運輸到細胞內以便進一步運用。它在肌肉和神經組織的功能中起著關鍵作用。鎂是合成所有蛋白質、核酸、核苷酸、環腺苷酸一磷酸、脂質及碳水化合物所必需的。

鎂是釋放能量所必需的，並促進體溫的正常調節及適當的神經功能，協助身體處理壓力，並且促進正常的新陳代謝。重要的是，身體也需要鎂來建立健康的骨骼和牙齒，促進肌肉的正常發展。鎂、鈣及維他命D一起使用，有助維持骨骼強壯。鎂能促進心血管健康。

錳(葡萄糖酸鈣)
錳是一種大量存在於植物和動物裡的礦物質。富含錳的食物來源包括全穀類、堅果、葉菜和茶。含錳濃度最高的是穀物的穀皮部份，但通常穀物在加工時，穀皮都會被去除。錳有多種不同的形式存在營養補充品中，包括葡萄糖酸錳、硫酸錳、抗壞血酸錳、氨基酸螯合錳等。
人體組織內僅含有微量的錳。錳主要儲存於骨骼、肝臟、腎臟和胰臟。它支援結締組織、骨骼及血液凝固因子的正常形成。它促進正常脂肪和碳水化合物的代謝，有助鈣質吸收，錳亦有助促進正常的大腦及神經功能。

鉀 (碳酸氫)
（碳酸氫鈉）富含鉀的食物包括了新鮮蔬果，例如香蕉、橙、哈蜜瓜、牛油果、生菠菜、椰菜及芹菜。鉀是幫助維持體液平衡的必要宏量礦物質。它還在各種生化和生理過程中發揮作用。此外，它還支援正常的神經脈衝，心臟、骨骼肌及平滑肌的收縮，製造能量，合成核酸，以及有助於維持細胞內滲透壓和血壓。鉀有助正常的肌肉放鬆，亦促進蛋白質的合成。鉀是一種電解質，促進正常心跳功能。鉀對於蛋白質、脂肪，與碳水化合物在代謝過程中的能量釋放也很重要。

鉀還有助於調節水分平衡，並有助恢復體力。鉀支援正常廢物清除。鉀促進正常的癒合，一般有助於提升身體健康感。鉀儲存於肌肉內。

硒（氨基酸螯合物）
硒的最佳飲食來源包括堅果、未加工穀類、糙米、小麥胚芽和海鮮。硒有助維他命E的抗氧化功效，也常被加入維他命E營養補充品內。作為抗氧化物，穀胱甘肽過氧化物酵素中的一部分，硒可直接保護細胞免受自由基的損害。

鋅（乳酸） 
鋅大量存在於營養強化的穀類、紅肉、蛋、家禽和蠔等海鮮中。鋅是多種酵素和蛋白質的組成物。與基因表現的調節有關。鋅是一種必要的微量礦物質，參與三百多種不同的酵素反應。因此，鋅支援幾乎所有的生物化學途徑和生過程中起作用。體內90%以上的鋅都儲存於骨骼和肌肉中，但是幾乎在所有的身體組織都含有鋅。據稱鋅支援正常的癒合和免疫系統。

生物素
含有生物素（維他命B7）的食物包括蛋黃，花生，牛肝，牛奶(10微克/杯)，早餐穀類，杏仁以及啤酒酵母。生物素有助維持細胞的健康成長，脂肪酸的製造，以及脂肪和氨基酸的代謝。它在檸檬酸循環中起作用，檸檬酸循環是在有氧呼吸過程中產生生化能量的過程。生物素不僅有助於各種代謝化學的轉化，同時也有助於二氧化碳的轉移。生物素通常被推薦用於強化頭髮和指甲。

常見問答

每份Isotonix基本營養組合包中有甚麼？
每個組合包中包括Isotonix OPC-3沖飲、Isotonix 綜合維他命沖飲、Isotonix全效維他命B沖飲及Isotonix鈣高效吸收沖飲。

Isotonix營養補充品為何比其他營養補充產品優勝？
Isotonix配方以最佳的方式傳輸維他命與礦物質的營養到血液中，因此比其他一般產品更有效。Isotonix配方亦是吸收維他命、礦物質和營養素的最快最有效方式。當食用Isotonix系列時，由於產品的酸鹼值與強度皆經精心設計，胃部幾乎不須處理即可將所有的營養素釋放到小腸中。藉著Isotonix的等滲透配方，大約5分鐘小腸即可吸收到營養，而一般的維他命錠劑卻可花上4小時才能完成。

Isotonix OPC-3沖飲與其他的生物類黃酮產品有何不同？
Isotonix OPC-3（含碧容健）提供經科學證實的原花色素(OPC)組合，這些原花色素已被證實對人體健康的功效是極高的。除了作為強效抗氧化物外，OPC-3中含有各種的原花色素，皆被證實能提供多方面的健康益處。OPC-3所包含的以科學為本的原花色素組合是獨有的，而它的Isotonix等滲透傳送系統也是同樣獨有的，這系統讓人體能迅速並高度有效地吸收原花色素。強效的營養成分加上高效的傳輸系統，讓OPC-3成為最有效清除自由基的產品。

為甚麼我需要食用綜合維他命？
高品質的維他命及礦物質營養補充品，能為均衡的飲食帶來完整的微量營養素基礎。維他命及礦物質有助於維繫健康的免疫系統，促進食物轉化為能量，維護心血管健康，促進骨骼強壯，保持頭腦清晰，維持正常的新陳代謝，促進健康發育及組織修護，並維持體內的水分和電解質平衡。

為甚麼維他命B群在老化的過程中這麼重要？
隨著年紀漸長，吸收B類維他命的能力自然下降，而認知功能受損的多種指標與B類維他命水平下降有關。許多長者都會味覺減退，因而影響食慾，可能會利用很多減少胃酸的藥物，使他們患上 B12 缺乏症。維他命B12是一種非常難以吸收並消化的營養，但也是參與多種人體機能的最重要維他命之一，這些機能包括神經系統的最佳運作、脫氧核糖核酸(DNA)及核糖核酸(RNA)的正常合成、能量的正常產生及血液的健康。

為甚麼我要補充鈣質？
根據美國公共衛生署長，每天服用鈣質營養補充品是預防和治療缺鈣症狀，以及幫助降低骨質疏鬆風險的關鍵。目前，本地超過三分之一的停經後的女性患有骨質疏鬆。最近臨床統計數據表明，老年男性也很可能會患上骨質疏鬆。

每個人都需要鈣質，基本上，沒有人能從日常飲食中攝入足夠的鈣。除有助於支持和維持骨骼的完整外，鈣也是相當重要的礦物質。在支持多種身體酵素活動及維持適當液體平衡方面，鈣的存在非常重要。Isotonix鈣高效吸收沖飲有助於骨骼與肌肉的正常收縮。

我既健康又愛好運動，為甚麼還要食用Isotonix OPC-3沖飲？
面對自由基不斷的侵害而造成的老化過程時，每個人都是一樣脆弱，而運動員面對的氧化壓力更高。氧氣與卡路里反應的代謝過程中，會產生自由基作為副產品。運動員運動時所吸入的氧氣量比靜止時高出10至20倍，而加大運動量會產生更多自由基。事實上，這些自由基也會影響運動員表現，因為自由基似乎也會影響肌肉組織。研究發現，業餘運動員食用原花色素後，耐力增加了20%，此研究採用的對照組別則食用外表相似的食品。另一項研究也顯示，食用原花色素的運動員在運動中與運動後的酸痛也大大減低。Isotonix OPC-3沖飲有助維持健康的血液流通，因此可支援氧氣運輸到肌肉。

Isotonix 基本營養組合包有任何使用上的限制或須注意事項嗎？
Isotonix OPC-3沖飲、Isotonix綜合維他命沖飲、Isotonix全效維他命B沖飲及Isotonix鈣高效吸收沖飲為素食產品且不含小麥、麩質、大豆、酵母、人工香料、澱粉、鹽或奶。

如果你患有疾病或正服用處方藥物，或為懷孕或哺乳中婦女，使用本品前，請先諮詢醫護人員意見。

本產品是否含有鐵質？
是的。每食用份量含4.5毫克鐵質。

本產品是否標示「不含可檢測出之基因改造生物」？ 
本產品未檢測出基因改造生物。本產品的原材料中或許含有基因改造的材料/成份，但其最終產品並不含任何轉殖基因片段或轉殖蛋白質。

Isotonix基本營養組合包安全嗎？
Isotonix基本營養組合包安全及不含有害物質。本產品在美國製造，並經美國食品及藥物管理局檢測設備生產，符合生產規範。顧客對本產品的質量和安全可絕對有信心。

科學

Isotonix OPC-3®沖飲
  • Bayeta, E., et al. Pycnogenol inhibits generation of inflammatory mediators in macrophages. Nutrition Research 20: 249-259, 2000.
  • Blazsó, G., et al. Anti-inflammatory and superoxide radical scavenging activities of a procyanidins containing extract from the bark of Pinus pinaster Sol. and its fractions. Pharm Pharmacol Lett 3: 217-20, 1994
  • Cesarone, M., et al. Improvement in Circulation and in Cardiovascular Risk Factors With a Proprietary Isotonic Bioflavanoid Formula OPC-3. Journal Angiology 59: 408-414, 2008.
  • Cho, K., et al. Effect of bioflavonoids extracted from the bark of Pinus maritima on proinflammatory cytokine interlukin-1 production in lipopolysaccharide-stimulated RAW 264. 7. Toxicology and Applied Pharmacology 168: 64-71, 2000.
  • Cho, K., et al. Inhibition mechanisms of bioflavonoids extracted from the bark of Pinus maritima on the expression of proinflammatory cytokines. Annals of the NYAcademy of Sciences 928: 141-156, 2001.
  • Devaraj, S., et al. Supplementation with a pine bark extract rich in polyphenols increases plasma antioxidant capacity and alters the plasma lipoprotein profile. Lipids 37:931-4, 2002.
  • Fine, AM, Oligomeric proanthocyanidin complexes: history, structure, and phytopharmaceutical applications. Altern Med Rev 5:144-51, 2000.
  • Fitzpatrick, D., et al. Endothelium-dependent vascular effects of Pycnogenol. Journal of Cardiovascular Pharmacology 32: 509-515, 1998.
  • Frankel, E., et al. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 341: 454-7, 1993.
  • Freedman, J., et al. Select flavonoids and whole juice from purple grapes inhibit platelet function and enhance nitric oxide release. Circulation 103:2792-8, 2001.
  • Frémont, L. Biological effects of resveratrol. Life Sciences 66: 663-673, 2000.
  • Gulati, O. Pycnogenol® in venous disorders: a review. European Bulletin of Drug Research 7: 1-13, 1999.
  • Hosseini, S., et al. Pycnogenol® in the management of asthma. Journal of Medicinal Food 4: 201-209, 2001. HHHh
  • Kohama, T., et al. The treatment of gynecological disorders with Pycnogenol®. European Bulletin of Drug Research 7: 30-32, 1999.
  • Kohama, T., et al. Analgesic efficacy of French maritime pine bark extract in dysmenorrhea. Journal of Reproductive Medicine 49: 828-32, 2004.
  • Liu, X., et al. Antidiabetic effect of Pycnogenol French maritime pine bark extract in patients with diabetes type II. Life Sci 75:2505-13, 2004.
  • Liu, X., et al. French maritime pine bark extract pycnogenol dose-dependently lowers glucose in type 2 diabetic patients. Diabetes Care 27: 839, 2004.
  • Manna, S., et al. Resveratrol suppresses TNF-Induced activation of nuclear transcription factors NF-kB, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. The Journal of Immunology 164: 6509-19, 2000.
  • Maritim, A., et al. Effects of pycnogenol treatment on oxidative stress in streptozotocin-induced diabetic rats. J Biochem Mol Toxicol 17:193-9, 2003.
  • Miyagi, Y., et al. Inhibition of human low-density lipoprotein oxidation by flavonoids in red wine and grape juice. Am J Cardiol 0:1627-31, 1997.
  • Monograph. Vaccinium myrtillus (bilberry). Altern Med Rev 6:500-4, 2001.
  • Murias M., et al. Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg Med Chem 12: 5571-8, 2004.
  • Nuttall SL, Kendall MJ, Bombardelli E, Morazzoni P. An evaluation of the antioxidant activity of a standardized grape seed extract, Leucoselect. J Clin Pharm Ther 23: 385-89, 1998.
  • Packer, L., et al. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, pycnogenol. Free Radic Biol Med 27:704-24, 1999. Review.
  • Rohdewald, P. A review of the French maritime pine bark extract (Pycnogenol®), a herbal medication with a diverse clinical pharmacology. Int J Clin Pharmacol Ther 40:158-68, 2002. Review.
  • Rohdewald, P. Pycnogenol®. In "Flavonoids in Health and Disease". Ed. Catherine Rice-Evans and Lester Packer. New York: Marcel Dekker, Inc., 1998. 405-19.
  • Roseff, S., et al. Improvement in sperm quality and function with French maritime pine tree bark extract. Journal Reproductive Medicine 47: 821-4, 2002.
  • Roseff, S., et al. Improvement of sperm quality by Pycnogenol®. European Bulletin of Drug Research 7: 33-6, 1999.
  • Saito, M., et al. Antiulcer activity of grape seed extract and procyanidins. J Agric Food Chem 46: 1460-4, 1998.
  • Schönlau, F., et al. Pycnogenol® for diabetic retinopathy. International Ophthalmology 24: 161-171, 2002.
  • Schönlau, F., et al. The cosmeceutical Pycnogenol®. J Appl Cosmetology 20: 241-6, 2002.
  • Segger, D. and Schönlau, F. Supplementation with Evelle® improves skin smoothness and elasticity in a double blind, placebo-controlled study with 62 women. Journal of Dermatological Treatment 15:222-26, 2004.
  • Shi, J., et al. Polyphenolics in grape seeds-biochemistry and functionality. J Med Food 6:291-9, 2003. Review.
  • Sharma, S., et al. Pycnogenol® inhibits the release of histamine from mast cells. Phytotherapy Research 17: 66-69, 2003.
  • Spadea, L., et al. Treatment of vascular retinopathies with Pycnogenol®. Phytotherapy Research 15: 219-23, 2001.
  • Stein, J., et al. Purple grape juice improves endothelial function and reduces the susceptibility of LDL cholesterol to oxidation in patients with coronary artery disease. Circulation 100:1050-5, 1999.
  • Takada, Y., et al. Nonsteroidal anti-inflammatory agents differ in their ability to suppress NF-kappaB activation, inhibition of expression of cyclooxygenase-2 and cyclin D1, and abrogation of tumor cell proliferation. Oncogene 23: 9247-58, 2004.
  • Ueda, T., et al. Preventative effect of natural and synthetic antioxidants on lipid peroxidation in the mammalian eye. Ophthalmic Res 28: 184-92, 1996.
  • Wallerath, T., et al. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 106:1652-8, 2002.
  • Watson, R. Pycnogenol® and cardiovascular health. Evidence-Based Integrative Medicine 1: 27-32, 2003.
  • Wei, Z., et al. Pycnogenol enhances endothelial cell antioxidant defense. Redox Report 3: 219-24, 1997.
  • Yamakoshi, J., et al. Proanthocyanidin-rich extract from grape seeds attenuates the development of aortic atherosclerosis in cholesterol-fed rabbits. Atherosclerosis 142:139-149, 1999.
  • Ames, BN, et al. Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 90:7915-7922, 1993.
  • Bagchi, D, et al. Oxygen free radical scavenging abilities of vitamins C and E, and a grape seed proanthocyanidin extract in vitro. Res Commun Mol Pathol Pharmacol 95:179-89, 1997.
  • Bagchi, D, et al. Free radicals and grape seed proanthocyanidin extract: importance in human health and disease prevention. Toxicology 148: 187-97, 2000.
  • Bagchi, D, et al. Cellular protection with proanthocyanidins derived from grape seed. Ann NY Acad Sci 957:260-70, 2002.
  • Cao G, Alessio H, Cultler R. Oxygen-radical absorbance capacity assay for antioxidants. Fre Rad Biol & Med 14:301-11, 1993.
  • Drew B, Leeuwenburgh C. Aging and the role of reactive nitrogen species. Ann NY Acad Sci 959:66-81, 2002.
  • Gibson, L, et al. Effectiveness of cranberry juice in preventing urinary tract infections in long-term care facility patients. J Naturopathic Med 2:45-47, 1991.
  • Graham DY, Smith JL, Bouvet, AA. What happens to tablets in the stomach. J Pharm Sci 79:420-24, 1990.
  • Havsteen B. Flavonoids, a class of natural products of high pharmacological potency. Biochem Pharm 32:1141-48, 1983.
  • Halpern, MJ, et al. Red wine polyphenols and inhibition of platelet aggregation: possible mechanisms, and potential use in health promotion and disease prevention. J Int Med Res 26:171-80, 1998.
  • Joseph JA, Shukitt-Hale B, Denisova NA, Bielinksi D, Martin A, McEwen JJ, Bickford PC. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neuroscience 19: 8114-21, 1999.
  • Kay CD, Holub BJ. The effect of wild blueberry (Vaccinium angustifolium) on post-prandial serum antioxidant status in human subjects. Br J Nutr 88: 389-98, 2002.
  • Kehrer JP. Free radicals as mediators of tissue injury and disease. Crit Rev Toxicol 23:21-48, 1993.
  • Koch R. Comparative study of Venostatin and Pycnogenol in chronic venous insufficiency. Phytother Res 16:S1-5, 2002.
  • Koparker AD, Augsburger LL, Shangraw RF. Intrinsic dissolution rates of tablet fillers and binders and their influence on the dissolution of drugs from tablet formulations. Pharm Res 7:80-85, 1990.
  • Mazza G, Kay CD, Cottrell T, Holub BJ. Absorption of anthocyanins from blueberries and serum antioxidant status in human subjects. J Agric Food Chem 50:7731-37, 2002.
  • Nesaretnam K, et al. Effect of tocotrienols on the growth of a human breast cancer cell line in culture. Lipids 30:1139-43, 1995.
  • Ofek I, Goldhar J, Zafriri D, Lis H, Sharon N. Anti-Escherichia coli adhesion activity of cranberry and blueberry juices. New England J Med 324:1599, 1991.
  • Qureshi, A, et al. Response of hypercholesterolemic subjects to administration of tocotrienols. Lipids 30:1171-77, 1995.
  • Rimbach G, Virgili F, Park YC, Packer L. Effect of procyanidins from Pinus maritime on glutathione levels in endothelial cells challenged by 3-morpholinosydnonimine or activated macrophages. Redox Rep 4:171-77, 1999.
  • Sobota AE. Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infactions. J Urology 131:1013-1016, 1984.
  • Soloway MS, Smith RA. J Am Med Assoc 260:1465, 1988.
  • Tomco, A, et al. Antioxidant effects of tocotrienol in patients with hyperlipidemia and carotid stenosis. Lipids 30: 1179-83, 1995.
  • Zheng W, Wang SY. Oxygen radical absorbing capacity of phenolics in blueberries, cranberries, chokeberries, and lingonberries. J Agric Food Chem 51:502-9, 2003.
  • Wilson D et al. A randomized, double-blind, placebo-controlled exploratory study to evaluate the potential of pycnogenol for improving allergic rhinitis symptoms. Phytother Res. 24(8):1115-9, 2010.
  • Lau B et al. Pycnogenol as an adjunct in the management of childhood asthma. J Asthma. 41(8):825-32, 2004.
  • Choi YH, Yan GH. Pycnogenol® inhibits immunoglobulin E-mediated allergic response in mast cells. Phytother Res 23: 1691-1695, 2009.
  • Sharma SC, Sharma S, Gulati OP. Pycnogenol® inhibits the release of histamine from mast cells. Phytother Res, 17: 66-69, 2003.
  • Hosseini S, Pishnamazi S, Sadrzadeh MH, Farid F, Farid R, Watson RR. Pycnogenol® in the management of asthma. J Med Food 4: 201-209, 2001.
Isotonix®綜合維他命沖飲
  • Abbasi AA, Prasad AS, Rabbani P, DuMouchelle E. Experimental zinc deficiency in man. Effect on testicular function. J Lab Clin Med. 1980 Sep;96(3):544-50.
  • Abid M, Billington CJ, Nuttall FQ. Thyroid function and energy intake during weight gain following treatment of hyperthyroidism. J Am Coll Nutr. 1999 Apr;18(2):189-93.
  • Addison WLT, The use of sodium chloride, potassium chloride, sodium bromide and potassium bromide in cases of arterial hypertension which are amenable to potassium chloride. Can Med Assoc J. 1928; 18:281-285.
  • Allende LM, Corell A, Madrono A, Gongora R, Rodriguez-Gallego C, Lopez-Goyanes A, Rosal M, Arnaiz-Villena A. Retinol (vitamin A) is a cofactor in CD3-induced human T-lymphocyte activation. Immunology. 1997 Mar;90(3):388-96
  • Anderson RA. Effects of chromium on body composition and weight loss. Nutr Rev. 1998 Sep;56(9):266-70.
  • Arthur JR. Functional indicators of iodine and selenium status. Proc Nutr Soc. 1999 May;58(2):507-12.
  • Backstrom MC, Maki R, Kuusela AL, Sievanen H, Koivisto AM, Ikonen RS, Kouri T, Maki M. Randomised controlled trial of vitamin D supplementation on bone density and biochemical indices in preterm infants. Arch Dis Child Fetal Neonatal Ed. 1999 May;80(3):F161-6.
  • Bahadori B, Wallner S, Schneider H, Wascher TC, Toplak H. Effect of chromium yeast and chromium picolinate on body composition of obese, non-diabetic patients during and after a formula diet. Acta Med Austriaca. 1997;24(5):185-7.
  • Baly DL, Schneiderman JS, Garcia-Welsh AL. Effect of manganese deficiency on insulin binding, glucose transport and metabolism in rat adipocytes. J Nutr. 1990; 120:1075-1079.
  • Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 1999;340:101-107.
  • Baron JA, Tosteson TD, Wargovich MJ, et al. Calcium supplementation and rectal mucosal proliferation: a randomized controlled trial. J Natl Cancer Inst 1995;87:1303-1307.
  • Bates CJ. Vitamin A. Lancet. 1995; 345:31-35.
  • Baxter GF, Sumeray MS, Walker JM. Infant size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies. Lancet. 1996; 348:1424-1426.
  • Behl C. Vitamin E and other antioxidants in neuroprotection. Int J Vitam Nutr Res. 1999 May;69(3):213-9. 4. Botterweck AA, van den Brandt PA, Goldbohm RA. Vitamins, carotenoids, dietary fiber, and the risk of gastric carcinoma: results from a prospective study after 6.3 years of follow-up. Cancer. 2000 Feb 15;88(4):737-48.
  • Bellamy MC, Gedney JA. Unrecognized iron deficiency in critical illness. Lancet. 1998; 352:1903.
  • Beutler E, Larsh SE, Gurney CW. Iron therapy in chronically fatigued nonanemic women: a double-blind study. Ann Intern Med. 1960; 52:378-394.
  • Bostick RM, Kushi LH, Wu Y, et al. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 1999;149:151-160.
  • Britton J, Pavord I, Richards K, et al. Dietary magnesium, lung function, wheezing, and airway hyper-reactivity in a random adult population sample. Lancet. 1994; 344:357-362.
  • Brown JE, Wahle KW Effect of fish-oil and vitamin E supplementation on lipid peroxidation and whole-blood aggregation in man. Clin Chim Acta. 1990 Dec 14;193(3):147-56.
  • Brun JF, Dieu-Cambrezy C, Charpiat A, Fons C, Fedou C, Micallef JP, Fussellier M, Bardet L, Orsetti A. Serum zinc in highly trained adolescent gymnasts. Biol Trace Elem Res. 1995 Jan-Mar;47(1-3):273-8.
  • Bruner AB, Joffe A, Duggan A, et al. Randomised study of cognitive effects of iron supplementation in non-anaemic iron-deficient adolescent girls. Lancet. 1996; 348:992-997.
  • Buchinger W, Lorenz-Wawschinek O, Semlitsch G, Langsteger W, Binter G, Bonelli RM, Eber O. Thyrotropin and thyroglobulin as an index of optimal iodine intake: correlation with iodine excretion of 39,913 euthyroid patients. Thyroid. 1997 Aug;7(4):593-7.
  • Butterfield DA, Koppal T, Subramaniam R, Yatin S. Vitamin E as an antioxidant/free radical scavenger against amyloid beta-peptide-induced oxidative stress in neocortical synaptosomal membranes and hippocampal neurons in culture: insights into Alzheimer's disease. Rev Neurosci. 1999;10(2):141-9
  • Calomme MR, Vandem Berghe DA. Supplementation of calves with s
  • Cappuccio FP, MacGregor GA. Does potassium supplementation lower blood pressure? A meta-analysis of published trials. J Hypertens. 1991; 9:465-473.
  • Carlisle EM. Silicon as a trace nutrient. Sci Total Environ. 1988; 73:95-106.
  • Carlisle EM. The nutritional essentiality of silicon. Nutr Rev. 1982; 40:193-198.
  • Casscells W. Magnesium and myocardial infarction. Lancet. 1994; 343:807-809.
  • Christiansen CW, Rieder MA, Silverstein EL, Gencheff NE. Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation. 1995; 92:2617-2621.
  • Comstock GW, Alberg AJ, Huang HY, Wu K, Burke AE, Hoffman SC, Norkus EP, Gross M, Cutler RG, Morris JS, Spate VL, Helzlsouer KJ. The risk of developing lung cancer associated with antioxidants in the blood: ascorbic acid, carotenoids, alpha-tocopherol, selenium, and total peroxyl radical absorbing capacity. Cancer Epidemiol Biomarkers Prev. 1997 Nov;6(11):907-16.
  • Cooke MS, Evans MD, Podmore ID, et al. Novel repair action of vitamin C upon in vivo oxidative DNA damage. FEBS Lett. 1998; 439:363-367.
  • Cooney RV, Franke AA, Hankin JH, Custer LJ, Wilkens LR, Harwood PJ, Le Marchand L. Seasonal variations in plasma micronutrients and antioxidants. Cancer Epidemiol Biomarkers Prev. 1995 Apr-May;4(3):207-15.
  • Couzy F, Lafargue P, Guezennec CY. Zinc metabolism in the athlete: influence of training, nutrition and other factors. Int J Sports Med. 1990 Aug;11(4):263-6.
  • Dallman PR. Iron deficiency and the immune response. Am J Clin Nutr. 1987; 46:329-334.
  • Daudu PA, Kelley DS, Taylor PC, Burri BJ, Wu MM. Effect of a low beta-carotene diet on the immune functions of adult women. Am J Clin Nutr. 1994 Dec;60(6):969-72.
  • Dawson-Hughes B. Vitamin D and calcium: recommended intake for bone health. Osteoporos Int. 1998;8 Suppl 2:S30-4. 6. Feit JM. Calcium and vitamin D supplements for elderly patients. J Fam Pract. 1997 Dec;45(6):471-2.
  • de Lourdes Lima M, Cruz T, Carreiro Pousada J, et al. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care. 1998; 21:682-686.
  • de Valk B, Marx JJM. Iron, atherosclerosis, and ischemic heart disease. Arch Int Med. 1999; 159:1542-1548.
  • Dietary Reference Intakes for Calcium, Phosphorous, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press; 1997.
  • Dorgan JF, Schatzkin A. Antioxidant micronutrients in cancer prevention. Hematol Oncol Clin North Am. 1991 Feb;5(1):43-68.
  • Dreon DM, Butterfield GE. Vitamin B6 utilization in active and inactive young men. Am J Clin Nutr. 1986 May;43(5):816-24.
  • Duffy SJ, Gokce N, Holbrook M, et al. Treatment of hypertension with ascorbic acid. Lancet. 1999; 354:2048-2049.
  • Durlach J, Durlach V, Bac P, et al. Magnesium and therapeutics. Magnes Res. 1994; 7:313-328.
  • Elisaf M, Merkouropoulos M, Tsianos EV. Siamopoulos KC. Pathogenetic mechanisms of hypomagnesemia in alcoholic patients. J Trace Elem Med Biol. 1995; 9:210-214.
  • Elitsur Y, Neace C, Liu X, Dosescu J, Moshier JA. Vitamin A and retinoic acids immunomodulation on human gut lymphocytes. Immunopharmacology. 1997 Jan;35(3):247-53.
  • Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology. 1992; 3:194-202.
  • Facchinetti F, Borella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991; 78:177-181.
  • Facchinetti F, Borella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991; 78:177-181.
  • Fairbanks VF. Iron in medicine and nutrition. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. Baltimore, MD: Williams and Wilkins; 1999:193-221.
  • Fang J, Madhavan S, Alderman MH. Dietary potassium intake and stroke mortality. Stroke. 2000; 31:1532-1537.
  • Fields M, Lewis CG. Starch diets high in iron can duplicate the severity of copper deficiency in rats fed fructose. J Med Food. 1998; 1:193-199.
  • Finch CA, Huebers H. Perspectives in iron metabolism. N Engl J Med. 1982; 306:1520-1528.
  • Flatt PR, Juntti-Berggren L, Berggren PO, Gould BJ, Swanston-Flatt SK. Failure of glucose tolerance factor-containing Brewer's yeast to ameliorate spontaneous diabetes in C57BL/KsJ DB/DB mice. Diabetes Res. 1989 Mar;10(3):147-51.
  • Futoryan T, Gilchrest BA. Retinoids and the skin. Nutr Rev. 1994; 52:299-310.
  • Gleeson M, Bishop NC. Elite athlete immunology: importance of nutrition. Int J Sports Med. 2000 May;21 Suppl 1:S44-50.
  • Grant KE, Chandler RM, Castle AL, Ivy JL. Chromium and exercise training: effect on obese women. Med Sci Sports Exerc. 1997 Aug;29(8):992-8.
  • Gullestad L, Dolva LO, Soyland E, et al. Oral magnesium supplementation improves metabolic variables and muscle strength in alcoholics. Alcohol Clin Exp Res. 1992; 16:986-990.
  • Guo WD, Chow WH, Zheng W, Li JY, Blot WJ. Diet, serum markers and breast cancer mortality in China. Jpn J Cancer Res. 1994 Jun;85(6):572-7.
  • Harris ED. Cellular copper transport and metabolism. Annu Rev Nutr. 2000; 20:291-310.
  • Harrison MD, Jones CE. Solioz M, Dameron CT. Intracellular copper routing: the role of copper chaperones. Trends Biochem Sci. 2000; 25:29-32.
  • Health & Medicine. (Statistical Data Included) American Fitness, July, 1999 Tannen RL. Effects of potassium on blood pressure control. Ann Intern Med. 1983; 98(part 2):773-780.
  • Hemila H, Douglas RM. Vitamin C and acute respiratory infections. Int J Tuberc Lung Dis. 1999; 3:756-761.
  • Hermans JJ, Fischer MA, Schiffers PM, Struijker-Boudier HA. High dietary potassium chloride intake augments rat renal mineralocorticoid receptor selectivity via 11beta-hydroxysteroid dehydrogenase. Biochim Biophys Acta. 1999; 1472:537-549.
  • Hermansen K. Diet, blood pressure and hypertension. Br J Nutr. 2000; 83 Supp1:S113-S119.
  • Hintze G, Kobberling J. Dietary iodine deficiency. Its consequences in the aged. Fortschr Med. 1992 Apr 10;110(10):163-6.
  • Huebers HA, Beguin Y, Pootrakul P, et al. Intact transferrin receptors in human plasma and their relation to erythropoiesis. Blood. 1990; 75:102-107.
  • Hughes K, Chua LH, Ong CN. Serum selenium in the general population of Singapore, 1993 to 1995. Ann Acad Med Singapore. 1998 Jul;27(4):520-3.
  • Hunt CD, Johnson PE, Herbel J, Mullen LK. Effects of dietary zinc depletion on seminal volume and zinc loss, serum testosterone concentrations, and sperm morphology in young men. Am J Clin Nutr. 1992 Jul;56(1):148-57.
  • Hwang J, Peterson H, Hodis HN, et al. Ascorbic acid enhances 17 beta-estradiol-mediated inhibition of oxidized low density lipoprotein formation. Atherosclerosis. 2000; 150:275-284.
  • Ishimitsu T, Tobian L, Sugimoto K, Everson T. High potassium diets reduce vascular and plasma lipid peroxides in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens. 1996; 18:659-673
  • Ishimitsu T, Tobian L, Sugimoto K, Lange JM. High potassium diets reduce macrophage adherence to vascular wall in stroke-prone spontaneously hypertensive rats. J Vasc Res. 1995; 32:406-412.
  • Ishimitsu T, Tobian L, Uehara Y, et al. Effect of high potassium diets on the vascular and renal prostaglandin system in stroke-prone spontaneously hypertensive rats. Prostaglandins Leukot Essent Fatty Acids. 1995; 53:255-260.
  • Ishimitsu T, Tobian L. High potassium diets reduce endothelial permeability in stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol. 1997; 23:241-245.
  • ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995; 345:669-685.
  • Jacobson SG, Cideciyan AV, Regunath G, et al. Night blindness in Sorsby's fundus dystrophy reversed by vitamin A. Nature Gen. 1995; 11:27-32.
  • Jin L, ChaoL, Chao J. Potassium supplement upregulates the expression of renal kalikrein and bradykinin B2 receptor in SHR. Am J Physiol. 1999; 276:F476-F484.
  • Johnson WT, Thomas AC. Copper deprivation potentiates oxidative stress in HL-60 cell mitochondria. Proc Soc Exp Biol Med. 1999; 221:147-152.
  • Kao WHL, Folsom AR, Nieto J, et al. Serum and dietary magnesium and the risk for type 2 diabetes mellitus (editorial). Arch. Int Med. 1999; 159:2151-2159.
  • Khaw K-T, Barrett-Conner E. Dietary potassium and stroke-associated mortality. N Engl J Med. 1987; 316:235-240.
  • Klevay LM. Cardiovascular disease from copper deficiency — a history. J Nutr. 2000; 130:489S-492S.
  • Klevay LM. Coronary heart disease: the zinc/copper hypothesis. Am J Clin Nutr. 1975; 28:764-774.
  • Knekt P, Jarvinen R, Seppanen R, Rissanen A, Aromaa A, Heinonen OP, Albanes D, Heinonen M, Pukkala E, Teppo L. Dietary antioxidants and the risk of lung cancer. Am J Epidemiol. 1991 Sep 1;134(5):471-9.
  • Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy. Lancet. 1995; 346:270-274.
  • Krishna GG, Miller E, Kapoor S. Increased blood pressure during potassium depletion in normotensive men. N Eng J Med. 1989; 320:1177-1182.
  • Krotkiewski M, Gudmundsson M, Backstrom P, Mandroukas K. Zinc and muscle strength and endurance. Acta Physiol Scand. 1982 Nov;116(3):309-11.
  • Kung AW, Janus ED. Thyroid dysfunction in ambulatory elderly Chinese subjects in an area of borderline iodine intake. Thyroid. 1996 Apr;6(2):111-4.
  • Lamberg L. Diet may affect skin cancer prevention. JAMA. 1998 May 13;279(18):1427-8.
  • Lee M-O, Han S-Y, Jiang S, et al. Differential effects of retinoic acid on growth and apoptosis in human colon cancer cell lines associated with the induction of retinoic acid receptor beta. Biochem Pharmacol. 2000; 59:485-496.
  • Lim R, Herzog WR. Magnesium for cardiac patients: is it a valuable treatment supplement? Contemp Int Med. 1998; 10:6-9.
  • Lin H, Young DB. Interactions between plasma potassium and epinephrine in coronary thrombosis in dogs. Circulation. 1994; 89:331-338.
  • Loeper J, Goy-Loeper J, Rozensztajn L, Fragny M. The antiatheromatous action of silicon. Atherosclerosis. 1979; 33:397-408.
  • LoPresti JS, Gray D, Nicoloff JT. Influence of fasting and refeeding on 3,3',5'-triiodothyronine metabolism in man. J Clin Endocrinol Metab. 1991 Jan;72(1):130-6.
  • Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995; 333:201-205.
  • Lukaski HC. Magnesium, zinc, and chromium nutriture and physical activity. Am J Clin Nutr. 2000 Aug;72(2 Suppl):585S-93S.
  • Luoma P. Antioxidants, infections and environmental factors in health and disease in northern Finland. Int J Circumpolar Health. 1998 Jul;57(2-3):109-13.
  • Ma G, Young DB, Clower BR. Inverse relationship between potassium intake and coronary artery disease in the cholesterol-fed rabbit. Am J Hypertens. 1999; 12:821-825.
  • Manore MM. Effect of physical activity on thiamine, riboflavin, and vitamin B-6 requirements. Am J Clin Nutr. 2000 Aug;72(2 Suppl):598S-606S.
  • Martini LA. Magnesium supplementation and bone turnover. Nutr Rev. 1999; 57:227-229.
  • Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 1998; 5:24-27.
  • McCabe RD, Backarich MA, Srivastava K, Young DB. Potassium inhibits free radical formation. Hypertension. 1994; 24:77-82.
  • McCabe RD, Young DB. Potassium inhibits cultural vascular smooth muscle proliferation. Am J Hypertens. 1994; 7:346-350.
  • McCarty MF. Chromium and other insulin sensitizers may enhance glucagon secretion: implications for hypoglycemia and weight control. Med Hypotheses. 1996 Feb;46(2):77-80.
  • McDonald R, Keen CL. Iron, zinc and magnesium nutrition and athletic performance. Sports Med. 1988 Mar;5(3):171-84.
  • Meunier PJ. Calcium, vitamin D and vitamin K in the prevention of fractures due to osteoporosis. Osteoporos Int. 1999;9 Suppl 2:S48-52.
  • Miller ER 3rd, Appel LJ, Levander OA, Levine DM. The effect of antioxidant vitamin supplementation on traditional cardiovascular risk factors. J Cardiovasc Risk. 1997 Feb;4(1):19-24.
  • Miller JW. Vitamin E and memory: is it vascular protection? Nutr Rev. 2000 Apr;58(4):109-11. Bell L, Halstenson CE, Halstenson CJ, et al. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med. 1992; 152:2441-2444.
  • Morse AC, Beard JL, Jones BC. A genetic development model of iron deficiency: biological aspects. Proc Soc Exp Biol Med. 1999; 220:147-152.
  • Ness AR, Chee D, Elliot P. Vitamin C and blood pressure—an overview. J Hum Hypertens. 1997; 11:343-350.
  • Nielsen FH. Ultratrace minerals. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease, 9th ed. Baltimore, MD: Williams and Wilkins; 1999:283-303.
  • Nielsen FH. Ultratrace minerals. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 199:283-303.
  • Nishi Y. Anemia and zinc deficiency in the athlete. J Am Coll Nutr. 1996 Aug;15(4):323-4.
  • Orchard TJ. Magnesium and type 2 diabetes mellitus (editorial). Arch Int Med. 1999; 159:2119-2120. Keen CL, Ensunsa JL, Watson MH, et al. Nutritional aspects of manganese from experimental studies. Neurotoxicol. 1999; 20:213-223.
  • Paul T, Meyers B, Witorsch RJ, Pino S, Chipkin S, Ingbar SH, Braverman LE. The effect of small increases in dietary iodine on thyroid function in euthyroid subjects. Metabolism. 1988 Feb;37(2):121-4.
  • Pauling L. Evolution and the need for ascorbic acid. Proc Natl Acad SciUSA. 1970; 67:1643-1648.
  • Pauling L. The significance of the evidence about ascorbic acid and the common cold. Proc Natl Acad SciUSA. 1971; 68:2678-2681.
  • Penn ND, Purkins L, Kelleher J, Heatley RV, Mascie-Taylor BH, Belfield PW. The effect of dietary supplementation with vitamins A, C and E on cell-mediated immune function in elderly long-stay patients: a randomized controlled trial. Age Ageing. 1991 May;20(3):169-74.
  • Podmore ID, Griffiths HR, Herbert KE, et al. Vitamin C exhibits pro-oxidant effects. Nature. 1998; 392:559.
  • Prasad AS, Cossack ZT. Neutrophil zinc: an indicator of zinc status in man. Trans Assoc Am Physicians. 1982;95:165-76.
  • Prasad AS. Zinc deficiency in human subjects. Prog Clin Biol Res. 1983;129:1-33.
  • Rayssiguier Y, Gueux E, Bussiere L, Mazur A. Copper deficiency increases the susceptibility of lipoproteins and tissues to peroxidation in rats. J Nutr. 1993; 123:1343-1348.
  • Reading SA. Chromium picolinate. J Fla Med Assoc. 1996 Jan;83(1):29-31.
  • Reinhardt W, Holtermann D, Benker G, Olbricht T, Jaspers C, Reinwein D. Effect of small doses of iodine on thyroid function during caloric restriction in normal subjects. Horm Res. 1993;39(3-4):132-7.
  • Rico H, Gallego-Lago JL, Hernandez ER, at al. Effect of silicon supplement on osteopenia induced by ovariectomy in rats. Calcif Tissue Int. 2000; 66:53-55.
  • Robuschi G, Emanuele R, Cavalli Sforza LT, Arsenio L, Strata A, Gnudi A, Roti E. Effect of iodine administration on thyroid function in diabetic patients. Acta Diabetol Lat. 1984 Oct-Dec;21(4):357-60.
  • Rock E, Mazur A, O'Connor JM, et al. The effect of copper supplementation on red blood cell oxidizability and plasma antioxidants in Middle-aged healthy volunteers. Free Rad Biol Med. 2000; 28:324-329.
  • Rokitzki L, Sagredos A, Keck E, Sauer B, Keul J. Assessment of vitamin B2 status in performance athletes of various types of sports. J Nutr Sci Vitaminol (Tokyo). 1994 Feb;40(1):11-22.
  • Ross AC, Stephensen CB. Vitamin A and retinoids in antiviral responses. FASEB J. 1996; 10:979-985.
  • Ross AC. Vitamin A and retinoids. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:305-327.
  • Saari JT, Sahuschke DA. Cardiovascular effects of dietary copper deficiency. Biofactors. 1999; 10:359-375.
  • Schwarz K. A bound form of silicon in glycosaminoglycans and polyuronides. Proc Nat Acad Sci. 1973; 70:1608-1612.
  • Schwarz K. Silicon, fibre, and atherosclerosis. Lancet. 1977; 1:454-457.
  • Scrimshaw NS, San Giovanni JP. Synergism of nutrition, infection, and immunity: an overview. Am J Clin N. 1997; 66:464S-477S.
  • Semba RD. The role of vitamin A and related retinoids in immune function. Nutr Rev. 1998 Jan;56(1 Pt 2):S38-48.
  • Semba RD. Vitamin A and immunity to viral, bacterial and protozoan infections. Proc Nutr Soc. 1999 Aug;58(3):719-27.
  • Semba RD. Vitamin A, immunity, and infection. Clin Infect Dis. 1994 Sep;19(3):489-99.
  • Shephard RJ, Shek PN. Immunological hazards from nutritional imbalance in athletes. Exerc Immunol Rev. 1998;4:22-48.
  • Silva JE. Effects of iodine and iodine-containing compounds on thyroid function. Med Clin North Am. 1985 Sep;69(5):881-98.
  • Singh MA. Combined exercise and dietary intervention to optimize body composition in aging. Ann N Y Acad Sci. 1998 Nov 20;854:378-93.
  • Skaper SD, Fabris M, Ferrari V, et al. quercetin protects cutaneous tissue-associated cell types including sensory neurons from oxidative stress induced by glutathione depletion: cooperative effects of ascorbic acid. Free Rad Biol Med. 1997; 22:669-678.
  • Sohlenius-Sternbeck A-K, Appelkvist E-L, De Pierre JW. Effects of vitamin A deficiency on selected xenobiotic-metabolizing enzymes and defenses against oxidative stress in mouse liver. Biochem Pharmacol. 2000; 59:377-383.
  • Stahelin HB. Critical reappraisal of vitamins and trace minerals in nutritional support of cancer patients. Support Care Cancer. 1993 Nov;1(6):295-7.
  • Strause L, Saltman P, Glowacki J. The effect of deficiencies of manganese and copper on osteo-induction and on resorption of bone particles in rats. Calcif Tissue Int. 1987; 41:145-150
  • Suboticanec K, Stavljenic A, Bilic-Pesic L, Gorajscan M, Gorajscan D, Brubacher G, Buzina R. Nutritional status, grip strength, and immune function in institutionalized elderly. Int J Vitam Nutr Res. 1989;59(1):20-8.
  • Sugimoto K, Tobian L, Ishimutsu T, Lange JM. High potassium diets greatly increase growth-inhibiting agents in aortas of hypertensive rats. Hypertension. 1992; 19:749-752.
  • Sugimoto T, Tobian L, Ganguli MC. High potassium diets protect against dysfunction of endothelial cells in stroke-prone spontaneously hypertensive rats. Hypertension. 1988:11:579-585.
  • Suzuki M, Itokawa Y. Effects of thiamine supplementation on exercise-induced fatigue. Metab Brain Dis. 1996 Mar;11(1):95-106.
  • Taddei S, Virdis A, Ghiadoni L, et al. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation. 1998; 97:2222-2229.
  • Takahashi T, Fujimori K, Simon SL, Bechtner G, Edwards R, Trott KR. Thyroid nodules, thyroid function and dietary iodine in the Marshall islands. Int J Epidemiol. 1999 Aug;28(4):742-9.
  • Tannen RL. Effects of potassium on blood pressure control. Ann Intern Med. 1983; 98(part 2):773-780.
  • Taylor PR, Li B, Dawsey SM, Li JY, Yang CS, Guo W, Blot WJ. Prevention of esophageal cancer: the nutrition intervention trials in Linxian, China. Linxian Nutrition Intervention Trials Study Group. Cancer Res. 1994 Apr 1;54(7 Suppl):2029s-2031s.
  • Thilly CH, Swennen B, Bourdoux P, Ntambue K, Moreno-Reyes R, Gillies J, Vanderpas JB. The epidemiology of iodine-deficiency disorders in relation to goitrogenic factors and thyroid-stimulating-hormone regulation. Am J Clin Nutr. 1993 Feb;57(2 Suppl):267S-270S.
  • Thurnham DI. Micronutrients and immune function: some recent developments. J Clin Pathol. 1997 Nov;50(11):887-91.
  • Tobian L. Salt and hypertension. Lessons from animal models that relate to human hypertension. Hypertension. 1991; 17:152-158.
  • Toyama T, Kubuki Y, Suzuki M. Tsubouchi H. [Copper deficiency anemia and neutropenia secondary to total gastrectomy]. [Article in Japanese]. Rinsho Ketsueki. 2000; 41:441-443.
  • Trent LK, Thieding-Cancel D. Effects of chromium picolinate on body composition. J Sports Med Phys Fitness. 1995 Dec;35(4):273-80.
  • Turnlund Jr. Copper. In: Shils ME, Olson JA, Shike M. Ross AC, eds. Modern Nutrition in health and Disease, 9th ed. Baltimore, MD: Williams and Wilkins; 1999:241-252.
  • Underwood BA, Arthur P. The contribution of vitamin A to public health. FASEB J. 1996; 10:1040-1048.
  • Uusitupa MI, Mykkanen L, Siitonen O, Laakso M, Sarlund H, Kolehmainen P, Rasanen T, Kumpulainen J, Pyorala K. Chromium supplementation in impaired glucose tolerance of elderly: effects on blood glucose, plasma insulin, C-peptide and lipid levels. Br J Nutr. 1992 Jul;68(1):209-16.
  • van den Brandt PA, Goldbohm RA, van 't Veer P, Bode P, Dorant E, Hermus RJ, Sturmans F. A prospective cohort study on selenium status and the risk of lung cancer. Cancer Res. 1993 Oct 15;53(20):4860-5.
  • van der Heyden JT, Docter R, van Toor H, Wilson JH, Hennemann G, Krenning EP. Effects of caloric deprivation on thyroid hormone tissue uptake and generation of low-T3 syndrome. Am J Physiol. 1986 Aug;251(2 Pt 1):E156-63.
  • Van Hooser JP, Aleman TS, He Y-G, et al. Rapid restoration of visual pigment and function with oral retinoid in a mouse model of childhood blindness. Proc Natl Acad Sci USA. 2000; 97:8623-8628.
  • Vatassery GT, Bauer T, Dysken M. High doses of vitamin E in the treatment of disorders of the central nervous system in the aged. Am J Clin Nutr. 1999 Nov;70(5):793-801.
  • Vatassery GT. Vitamin E and other endogenous antioxidants in the central nervous system. Geriatrics. 1998 Sep;53 Suppl 1:S25-7.
  • Waggoner DJ, Bartnikas TB, Gitlin JD. The role of copper in neurodegenerative disease. Neurobiology of Disease. 1999; 6:221-230.
  • Wahl R, Pilz-Mittenburg KW, Heer W, Kallee E. Iodine content in diet and excretion of iodine in urine. Z Ernahrungswiss. 1995 Dec;34(4):269-76.
  • Walker LS, Bemben MG, Bemben DA, Knehans AW. Chromium picolinate effects on body composition and muscular performance in wrestlers. Med Sci Sports Exerc. 1998 Dec;30(12):1730-7.
  • Wang Y, Mackenzie B, Tsukaguchi H, et al. Human vitamin C (L-ascorbic acid) transporter SVCT1. Biochem Biophys Res Commun. 2000; 267:488-494.
  • Wargovich MJ, Eng VWS, Newmark HL. Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett. 1984; 23:253-258.
  • Weaver CM, Heaney RP. Calcium. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:141-155.
  • West KP Jr, Pokhrel RP, Katz J, et al. Efficacy of vitamin A in reducing preschool child mortality in Nepal. Lancet. 1991; 338:67-71.
  • West SG, Light KC, Hinderliter AL, et al. Potassium supplementation induces beneficial cardiovascular changes during rest and stress in salt sensitive individuals. Health Psychol. 1999; 18:229-240.
  • Whelton PK, He J, Cutler JA, et al. Effects of oral potassium on blood pressure. Meta-analysis of randomized controlled clinical triglyceride trials. JAMA. 1997; 277:1624-1632.
  • Wolf RL, Cauley JA, Baker CE, et al. Factors associated with calcium absorption efficiency in pre- and perimenopausal women. Am J Clin Nutr. 2000; 72:466-471.
  • Young DB, Lin H, McCabe RD. Potassium's cardiovascular protective mechanisms. Am J Physiol. 1995; 268:R825-R837.
  • Young DB, Ma G. Vascular protective effects of potassium. Semin Nephrol. 1999; 19:477-486.
  • Zemel MB, Shi H, Greer B, et al. Regulation of adiposity by dietary calcium. FASEB J. 2000; 14:1132-1138.
  • Zhou B, Wang T, Sun G, Guan P, Wu JM. A case-control study of the relationship between dietary factors and risk of lung cancer in women of Shenyang, China. Oncol Rep. 1999 Jan-Feb;6(1):139-43.
  • Zhou MS, Nishida Y, Yoneyama H, et al. Potassium supplementation increases sodium excretion in hypertensive Dahl rats. Clin Exp Hypertens.
Isotonix®全效維他命B沖飲
  • Benton D., et al. Thiamine supplementation for mood and cognitive functioning. Psychopharmacology. 129(1):66-71, 1997.
  • Benton, D., et al. The effects of nutrients on mood. Public Health Nutr. 2(3A):403-409, 1999.
  • Bhagavan, H. N., et al. The effect of pyridoxine hydrochloride on blood serotonin and pyridoxal phosphate contents in hyperactive children. Pediatrics. 55(3):437-441, 1975.
  • Bronstrup A, Hages M, Prinz-Langenohl R, Pietrzik K. Effects of folic acid
  • Bryan, J., et al. Associations between dietary intake of folate and vitamins B-12 and B-6 and self-reported cognitive function and psychological well-being in Australian men and women in midlife. J Nutr Health Aging. 8(4):226-232, 2004.
  • Bryan, J., et al. Short-term folate, vitamin B-12 or vitamin B-6 supplementation slightly affects memory performance but not mood in women of various ages. Journal of Nutrition. 132(6):1345-1356, 2002.
  • combinations of folic acid and vitamin B12 on plasma homocysteine concentrations in healthy young women. Am J Clin Nutr 68:1104-10, 1998.
  • Coppen, A., et al. Plasma folate and affective morbidity during long-term lithium therapy. Br J Psychiatry. 141:87-89, 1982.
  • Cummings, P. M., et al. Effect of folic acid and antioxidant vitamins on endothelial dysfunction in patients with coronary artery disease. J Am Coll Cardiol. 36:758-765, 2000.
  • Dharmarajan, T. S., et al. Vitamin B12 deficiency. Recognizing subtle symptoms in older adults. Geriatrics. 58(3):30-34, 2003.
  • Doshi, S. N., et al. Folic acid improves endothelial function in coronary artery disease via mechanisms largely independent of homocysteine lowering. Circulation. 105(1):22-26, 2002.
  • Duthie, S. J., et al. Homocysteine, B vitamin status, and cognitive function in the elderly. American Journal of Clinical Nutrition. 75(5):908-913, 2002.
  • Friso, S., et al. Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk. Am J Clin Nutr. 79(6):992-998, 2004.
  • Grant, J. E., et al. Analysis of dietary intake and selected nutrient concentrations in patients with chronic fatigue syndrome. J Am Diet Assoc. 96(4):383-386, 1996.
  • Hartvig, P., et al. Pyridoxine effect on synthesis rate of serotonin in the monkey brain measured with position emission tomography. Neural Trans. 102:91-97, 1995.
  • Heap, L. C., et al. Vitamin B status in patients with chronic fatigue syndrome. J R Soc Med. 92(4):183-185, 1999.
  • Heseker, H., et al. Psychological disorders as early symptoms of a mild-to-moderate vitamin deficiency. Ann N Y Acad Sci. 669:352-357, 1992.
  • Jacobson, W., et al. Serum folate and chronic fatigue syndrome. Neurology. 43:2645-2647, 1993.
  • Kelly, G. S. Nutritional and botanical interventions to assist with the adaptation to stress. Alternative Medicine Review.4(4):249-265, 1999.
  • Litoff, D., et al. Effects of pantothenic acid supplementation on human exercise. Med Sci Sport Exercise., 17(Supplement):287, 1985.
  • Osada, K., et al. Experimental study of fatigue provoked by biotin deficiency in mice. Int J Vitam Nutr Res. 74(5):334-340, 2004.
  • Quadri, P., et al. Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr. 80(1):114-122, 2004.
  • Riggs, K. M., et al. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. American Journal of Clinical Nutrition. 63(3):306-314, 1996.
  • Van den Berg M., et al. Combined vitamin B-6 plus folic acid therapy in young patients with arteriosclerosis and hyperhomocysteinemia. Journal Vascular Surgery. 20(6):933-940, 1994.
  • van Oort FV, Melse-Boonstra A, Brouwer IA, et al. Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study. 77:1318-23, 2003.
  • Vargiu, R., et al. Enhancement of muscular performance by a coformulation of propionyl-L-carnitine, coenzyme Q(10), nicotinamide, riboflavin and pantothenic acid in the rat. Physiol Behav. 76(2):257-63, 2002.
  • Wald DS, Bishop L, Wald NJ, et al. Randomized trial of folic acid supplementation and serum homocysteine levels. Arch Intern Med 61:695-700, 2001.
  • Werbach, M. R. Nutritional strategies for treating chronic fatigue syndrome. Alternative Medicine Review. 5(2):93-108, 2000.
  • Woo, K. S., et al. Long-term improvement in homocysteine levels and arterial endothelial function after 1-year folic acid supplementation. American Journal of Medicine. 112(7):535-539, 2002.
Isotonix®鈣高效吸收沖飲
  • Allender PS, Cutler JA, Follman D, et al. Dietary calcium and blood pressure: meta—analysis of randomized clinical trials. Ann Intern Med. 1996; 124:825-831.
  • Altura BM, Altura BT. Role of magnesium and calcium in alcohol-induced hypertension and strokes as probed by in vivo television microscopy, digital image microscopy, optical spectroscopy, 31P-NMR, spectroscopy and a unique magnesium ion-selective electrode. Alcohol Clin Exp Res. 1994; 18:1057-1068.
  • Baly DL, Schneiderman JS, Garcia-Welsh AL. Effect of manganese deficiency on insulin binding, glucose transport and metabolism in rat adipocytes. J Nutr. 1990; 120:1075-1079.
  • Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. N Engl J Med 1999;340:101-107.
  • Baron JA, Tosteson TD, Wargovich MJ, et al. Calcium supplementation and rectal mucosal proliferation: a randomized controlled trial. J Natl Cancer Inst 1995;87:1303-1307.
  • Baxter GF, Sumeray MS, Walker JM. Infant size and magnesium: insights into LIMIT-2 and ISIS-4 from experimental studies. Lancet. 1996; 348:1424-1426.
  • Beattie JH, Peace HS. The influence of a low-boron diet and boron supplementation on bone, major mineral and sex steroid metabolism in postmenopausal women. Br J Nutr. 1993 May;69(3):871-84.
  • Bell L, Halstenson CE, Halstenson CJ, et al. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med. 1992; 152:2441-2444.
  • Bostick RM, Kushi LH, Wu Y, et al. Relation of calcium, vitamin D, and dairy food intake to ischemic heart disease mortality among postmenopausal women. Am J Epidemiol 1999;149:151-160.
  • Britton J, Pavord I, Richards K, et al. Dietary magnesium, lung function, wheezing, and airway hyper-reactivity in a random adult population sample. Lancet. 1994; 344:357-362.
  • Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. Ann Intern Med. 1996; 125:961-968.
  • Casscells W. Magnesium and myocardial infarction. Lancet. 1994; 343:807-809.
  • Christiansen CW, Rieder MA, Silverstein EL, Gencheff NE. Magnesium sulfate reduces myocardial infarct size when administered before but not after coronary reperfusion in a canine model. Circulation. 1995; 92:2617-2621.
  • Christin Marandino, Vegetarian Times, August 1998
  • Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affecting the risk of kidney stones in women. Ann Intern Med. 1997; 126:497-504.
  • Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density on men and women 65 years of age and older. N Engl J Med. 1997; 337:670-676.
  • de Lourdes Lima M, Cruz T, Carreiro Pousada J, et al. The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes. Diabetes Care. 1998; 21:682-686.
  • Dietary Reference Intakes for Calcium, Phosphorous, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press; 1997.
  • Durlach J, Durlach V, Bac P, et al. Magnesium and therapeutics. Magnes Res. 1994; 7:313-328.
  • Elisaf M, Merkouropoulos M, Tsianos EV. Siamopoulos KC. Pathogenetic mechanisms of hypomagnesemia in alcoholic patients. J Trace Elem Med Biol. 1995; 9:210-214.
  • Facchinetti F, Borella P, Sances G, et al. Oral magnesium successfully relieves premenstrual mood changes. Obstet Gynecol. 1991; 78:177-181.
  • Garland CF, Garland FC, Gorham ED. Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann NY Acad Sci. 1999; 889:107-119.
  • Gong H, Amemiya T. Optic nerve changes in manganese-deficient rats. Exp Eye Res. 1999; 68:313-320.
  • Gullestad L, Dolva LO, Soyland E, et al. Oral magnesium supplementation improves metabolic variables and muscle strength in alcoholics. Alcohol Clin Exp Res. 1992; 16:986-990.
  • Health & Medicine. (Statistical Data Included) American Fitness, July, 1999 Tannen RL. Effects of potassium on blood pressure control. Ann Intern Med. 1983; 98(part 2):773-780.
  • Heaney RP. Calcium, dairy products and osteoporosis. J Am Coll Nutr. 2000; 19(2 Suppl):83S-99S.
  • Hussain S, Ali SF. Manganese scavenges superoxide and hydroxyl radicals: an in vitro study in rats. Neuroscience Letters. 1999; 261:21-24.
  • ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulfate in 58,050 patients with suspected acute myocardial infarction. Lancet. 1995; 345:669-685.
  • Jorde R, Sundsfjord J, Haug E, et al. Relation between low calcium intake, parathyroid hormone, and blood pressure. Hypertension 2000;35:1154-1159.
  • Kao WHL, Folsom AR, Nieto J, et al. Serum and dietary magnesium and the risk for type 2 diabetes mellitus (editorial). Arch. Int Med. 1999; 159:2151-2159.
  • Keen CL, Ensunsa JL, Watson MH, et al. Nutritional aspects of manganese from experimental studies. Neurotoxicol. 1999; 20:213-223.
  • Krieger D, Krieger S, Jansen O, et al. Manganese and chronic hepatic encephalopathy. Lancet. 1995; 346:270-274.
  • Lim R, Herzog WR. Magnesium for cardiac patients: is it a valuable treatment supplement? Contemp Int Med. 1998; 10:6-9.
  • Lipkin M, Newmark H. Effect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer. N Engl J Med. 1985; 313:1381-1384.
  • Lucas MJ, Leveno KJ, Cunningham FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med. 1995; 333:201-205.
  • Martini LA. Magnesium supplementation and bone turnover. Nutr Rev. 1999; 57:227-229.
  • Mauskop A, Altura BM. Role of magnesium in the pathogenesis and treatment of migraines. Clin Neurosci. 1998; 5:24-27.
  • Naghii MR, Wall PM, Samman S. The boron content of selected foods and the estimation of its daily intake among free-living subjects. J Am Coll Nutr. 1996 Dec;15(6):614-9.
  • Newnham RE. Essentiality of boron for healthy bones and joints. Environ Health Perspect. 1994;102:83-85
  • Nielsen FH. Studies on the relationship between boron and magnesium which possibly affects the formation and maintenance of bones. Magnes Trace Elem. 1990;9:61-69
  • Nielsen FH. Ultratrace minerals. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease, 9th ed. Baltimore, MD: Williams and Wilkins; 1999:283-303.
  • Oginni LM, Sharp CA, Worsfold M, et al. Healing of rickets after calcium supplementation. Lancet. 1999; 353:296-297.
  • Orchard TJ. Magnesium and type 2 diabetes mellitus (editorial). Arch Int Med. 1999; 159:2119-2120.
  • Paolisso G, Sgamabato S, Pizza G, et al. Improved insulin response and action by chronic magnesium administration in aged NIDDM. Diabetes Care. 1989; 12:265-269.
  • Peikert A, Wilimzig C, Kohne-Volland R. Prophylaxis of migraine with oral magnesium: results from a prospective, multi-center, placebo-controlled and double-blind randomized study. Cephalalgia. 1996; 16:257-263.
  • Penland J.G. The importance of boron nutrition for brain and psychological function. Biol Trace Elem Res. 1998; 66:299-317.
  • Recker RR. Calcium absorption and achlorhydria. N Engl J Med. 1985; 313:70-73. Reid IR, Ames RW, Evans MC, et al. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med. 1993; 328:460-464.
  • Rivlin RS. Magnesium deficiency and alcohol intake: mechanisms, clinical significance and possible relation to cancer development (a review). J Am Coll Nutr. 1994; 13:416-423.
  • Roberts JM. Magnesium for preeclampsia and eclampsia. N Engl J Med. 1995; 333:250-251.
  • Roffe C, Fletcher S, Woods KL. Investigation of the effects of intravenous magnesium sulphate on cardiac rhythm in acute myocardial infarction. Br Heart J. 1994; 71:141-145.
  • Saris N-EL, Mervaala E, Karppanen H, et al. Magnesium. An update on physiological, clinical and analytical aspects (review). Clinica Chimica Acta. 2000; 294:1-26.
  • Shils ME. Magnesium. In: Shils M, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:169-192.
  • Singh MA. Combined exercise and dietary intervention to optimize body composition in aging. Ann N Y Acad Sci. 1998 Nov 20;854:378-93.
  • Singh N, Singh PN, Hershman JM. Effect of calcium carbonate on the absorption of levothyroxine. JAMA. 2000; 283:2822-2825.
  • Sojka JE. Magnesium supplementation and osteoporosis. Nutr Rev. 1995; 53:71-80.
  • Strause L, Saltman P, Glowacki J. The effect of deficiencies of manganese and copper on osteo-induction and on resorption of bone particles in rats. Calcif Tissue Int. 1987; 41:145-150
  • Strause L, Saltman P, Smith KT, et al. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr. 1994; 124:1060-1064.
  • Sutherland B, Strong P, King JC. Determining human dietary requirements for boron. Biol Trace Elem Res. 1998 Winter;66(1-3):193-204.
  • Talbot JR, Guardo P, Seccia S, et al. Calcium bioavailability and parathyroid hormone acute changes after oral intake of dairy and nondairy products in healthy volunteers. Osteoporosis Int. 1999; 10:137-142.
  • Tobian L. Salt and hypertension. Lessons from animal models that relate to human hypertension. Hypertension. 1991; 17:152-158.
  • Tosiello L. Hypomagnesemia and diabetes mellitus. A review of clinical implications. Arch Intern Med. 1998; 156:1143-1148.
  • Volpe SL, Taper LJ, Meacham S. The relationship between boron and magnesium status and bone mineral density in the human: a review. Magnes Res. 1993;6:291-296
  • Wargovich MJ, Eng VWS, Newmark HL. Calcium inhibits the damaging and compensatory proliferative effects of fatty acids on mouse colon epithelium. Cancer Lett. 1984; 23:253-258.
  • Weaver CM, Heaney RP. Calcium. In: Shils ME, Olson JA, Shike M, Ross AC, eds. Modern Nutrition in Health and Disease. 9th ed. Baltimore, MD: Williams and Wilkins; 1999:141-155.
  • Wolf RL, Cauley JA, Baker CE, et al. Factors associated with calcium absorption efficiency in pre- and perimenopausal women. Am J Clin Nutr. 2000; 72:466-471.
  • Woods KL, Fletcher S. Long-term outcome after intravenous magnesium sulphate in suspected acute myocardial infarction: the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2). Lancet. 1994; 343:816-819.
  • Zemel MB, Shi H, Greer B, et al. Regulation of adiposity by dietary calcium. FASEB J. 2000; 14:1132-1138.

評論

顧客評價
  • (81)
  • (3)
  • (0)
  • (1)
  • (0)
發表評論

顯示  1 - 5 的 85

19/9/2023

而 Ng

Everything I need

Very convenient blend! Great travel buddy!

顧客服務部的回覆
19/9/2023

Dear Valued Customer,
Thank you for taking the time to leave your thoughts on Isotonix® Daily Essentials Packets - Single Box (30 Packets). Thank you again for your support to Market America.
UnFranchsie Services Department

22/6/2022

而 匿名

孕婦可使用嗎

想請問孕婦可以喝嗎

顧客服務部的回覆
27/6/2022

感謝您聯絡美安公司。懷孕或哺乳期間的婦女，請在飲用本產品前先諮詢醫護人員。提供您參考，謝謝您。

17/7/2021

而 匿名

全家日常用品

十二歲男童每天可以飲用嗎？

顧客服務部的回覆
18/7/2021


致 親愛的顧客，

謝謝您抽出寶貴時間對Isotonix®基本營養組合包 提出寶貴意見，超連鎖店主服務部將與您聯繫，並協助解決此問題。

如果您想直接致電給我們，請在週一至週五的上午11:00至下午7:00之間致電852-35129198與我們聯繫。

再次感謝閣下對美安的支持!

超連鎖店主服務部 謹啟

19/6/2021

而 CHEUNG

產品非常好、具備四種Isotonix 的成份，明顯在身體健康上有改變、變得更好

產品非常好、具備四種Isotonix 的成份，明顯在身體健康上有改變、變得更好

顧客服務部的回覆
19/6/2021


致 親愛的顧客,

感謝您抽出寶貴時間對Isotonix®基本營養組合包 發表意見。 我們很高興您對產品感到滿意。

再次感謝閣下對美安的支持!

超連鎖店主服務部 謹啟

29/5/2021

而 Lo

老人家明顯精神了

家中老人喜歡每天喝這個，精神好多了

顧客服務部的回覆
30/5/2021


致 親愛的顧客,

感謝您抽出寶貴時間對Isotonix®基本營養組合包發表意見。 我們很高興您對產品感到滿意。

再次感謝閣下對美安的支持!

超連鎖店主服務部 謹啟

你也許對下列項目會有興趣: